Pharmacy messaging For GLP-1 products excluded from Part D when used for weight loss but potentially eligible under the Bridge, CMS encourages sponsors to assist with directing the claim to the Bridge for review, including use of the recommended pharmacy message with the Bridge BIN and PCN information
Diabetic patients have elevated fasting plasma glucagon levels that fail to suppress normally after a meal (17) (Figure 1)
Smaller meals reduce the volume the slowed stomach must process, decreasing the trigger for nausea and reflux
Keep a log of readings along with associated symptoms, timing relative to semaglutide doses, and any relevant activities or dietary factors
DNA methylation of GSTP1 in human prostate tissues: pyrosequencing analysis
Soliman A, Sanctis VD, Elalaily R, et al